Related Articles for PubMed (Select 18341711)

Rheumatologists, take heart! We may be doing something right.

van Vollenhoven RF.

Arthritis Res Ther. 2008;10(2):105. Epub 2008 Mar 7.

PMID: 18341711 [PubMed - indexed for MEDLINE]

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.

Naranjo A, Sokka T, Descalzo MA, Calvo-Alén J, Hørslev-Petersen K, Luukkainen RK, Combe B, Burmester GR, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Tunc R, Dimic A, Bergman M, Toloza S, Pincus T; QUEST-RA Group.

Arthritis Res Ther. 2008;10(2):R30. Epub 2008 Mar 6.

PMID: 18325087 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

Listing J, Strangfeld A, Kekow J, Schneider M, Kapelle A, Wassenberg S, Zink A.

Arthritis Rheum. 2008 Mar;58(3):667-77.

PMID: 18311816 [PubMed - indexed for MEDLINE]

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.

PMID: 16705046 [PubMed - indexed for MEDLINE]

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Arthritis Rheum. 2006 Aug;54(8):2368-76.

PMID: 16868999 [PubMed - indexed for MEDLINE]

Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis.

Boyer JF, Cantagrel A, Constantin A.

Curr Vasc Pharmacol. 2008 Jul;6(3):218-27. Review.

PMID: 18673161 [PubMed - indexed for MEDLINE]

What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

Dixon WG, Symmons DP.

Ann Rheum Dis. 2007 Sep;66(9):1132-6. Epub 2007 Jan 24. Review.

PMID: 17251223 [PubMed - indexed for MEDLINE]

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

Dixon WG, Watson KD, Lunt M, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Arthritis Rheum. 2007 Sep;56(9):2905-12.

PMID: 17763428 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis.

Doan QV, Chiou CF, Dubois RW.

J Manag Care Pharm. 2006 Sep;12(7):555-69. Review.

PMID: 16981801 [PubMed - indexed for MEDLINE]

10:

Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.

Avouac J, Allanore Y.

Expert Opin Pharmacother. 2008 May;9(7):1121-8. Review.

PMID: 18422470 [PubMed - indexed for MEDLINE]

11:

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.

Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, Schneeweiss S.

Arthritis Rheum. 2006 Dec;54(12):3790-8.

PMID: 17136752 [PubMed - indexed for MEDLINE]

12:

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D, Fischkoff SA, Chartash EK.

J Rheumatol. 2003 Dec;30(12):2563-71.

PMID: 14719195 [PubMed - indexed for MEDLINE]

13:

Biologics and heart failure in rheumatoid arthritis: are we any wiser?

Danila MI, Patkar NM, Curtis JR, Saag KG, Teng GG.

Curr Opin Rheumatol. 2008 May;20(3):327-33. Review.

PMID: 18388526 [PubMed - indexed for MEDLINE]

14:

Modelling the cost effectiveness of TNF-alpha antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.

Brennan A, Bansback N, Nixon R, Madan J, Harrison M, Watson K, Symmons D.

Rheumatology (Oxford). 2007 Aug;46(8):1345-54. Epub 2007 Jun 11.

PMID: 17562686 [PubMed - indexed for MEDLINE]

15:

Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.

Nurmohamed MT, van Halm VP, Dijkmans BA.

Drugs. 2002;62(11):1599-609. Review.

PMID: 12109923 [PubMed - indexed for MEDLINE]

16:

Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.

Bernatsky S, Hudson M, Suissa S.

Rheumatology (Oxford). 2007 Jul;46(7):1157-60. Epub 2007 May 3.

PMID: 17478469 [PubMed - indexed for MEDLINE]

17:

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

Dixon WG, Symmons DP, Lunt M, Watson KD, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ; British Society for Rheumatology Biologics Register.

Arthritis Rheum. 2007 Sep;56(9):2896-904.

PMID: 17763441 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

18:

TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma.

Sarzi-Puttini P, Atzeni F, Shoenfeld Y, Ferraccioli G.

Autoimmun Rev. 2005 Mar;4(3):153-61. Review.

PMID: 15823501 [PubMed - indexed for MEDLINE]

19:

Recapitulation of the round-table discussion--assessing the role of anti-tumour necrosis factor therapy in the treatment of rheumatoid arthritis.

Furst DE, Keystone E, Maini RN, Smolen JS.

Rheumatology (Oxford). 1999 Nov;38 Suppl 2:50-3.